3/2
07:09 am
tcrt
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders [Yahoo! Finance]
Neutral
Report
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders [Yahoo! Finance]
3/2
06:30 am
tcrt
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders
Medium
Report
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders
1/5
08:13 am
tcrt
Kailera Therapeutics Appoints Doug Pagán as Chief Financial Officer [Yahoo! Finance]
Neutral
Report
Kailera Therapeutics Appoints Doug Pagán as Chief Financial Officer [Yahoo! Finance]